These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28527688)

  • 1. Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae.
    Gbédandé K; Fievet N; Viwami F; Ezinmegnon S; Issifou S; Chippaux JP; Dossou Y; Moutairou K; Massougbodji A; Ndam N; de Jongh WA; Søgaard TMM; Salanti A; Nielsen MA; Esen M; Mordmüller B; Deloron P; Luty AJF;
    Vaccine; 2017 Jun; 35(27):3474-3481. PubMed ID: 28527688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and Insights Toward an Effective Placental Malaria Vaccine.
    Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA
    Front Immunol; 2021; 12():634508. PubMed ID: 33717176
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Tornyigah B; d'Almeida T; Escriou G; Viwami F; Fievet N; Luty AJF; Massougbodji A; Nielsen MA; Deloron P; Tuikue Ndam N
    Front Immunol; 2021; 12():610305. PubMed ID: 33968015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
    Mordmüller B; Sulyok M; Egger-Adam D; Resende M; de Jongh WA; Jensen MH; Smedegaard HH; Ditlev SB; Soegaard M; Poulsen L; Dyring C; Calle CL; Knoblich A; Ibáñez J; Esen M; Deloron P; Ndam N; Issifou S; Houard S; Howard RF; Reed SG; Leroy O; Luty AJF; Theander TG; Kremsner PG; Salanti A; Nielsen MA
    Clin Infect Dis; 2019 Oct; 69(9):1509-1516. PubMed ID: 30629148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and new horizons toward a VAR2CSA-based placental malaria vaccine.
    Doritchamou JYA; Suurbaar J; Tuikue Ndam N
    Expert Rev Vaccines; 2021 Feb; 20(2):215-226. PubMed ID: 33472449
    [No Abstract]   [Full Text] [Related]  

  • 6. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes.
    Fried M; Kurtis JD; Swihart B; Morrison R; Pond-Tor S; Barry A; Sidibe Y; Keita S; Mahamar A; Andemel N; Attaher O; Dembele AB; Cisse KB; Diarra BS; Kanoute MB; Narum DL; Dicko A; Duffy PE
    Malar J; 2018 Mar; 17(1):106. PubMed ID: 29523137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses.
    Gbédandé K; Cottrell G; Vianou B; Ibitokou S; Fernando A; Troye-Blomberg M; Salanti A; Moutairou K; Massougbodji A; Ndam NT; Deloron P; Luty AJ; Fievet N
    Malar J; 2016 Sep; 15(1):485. PubMed ID: 27653505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of functional assays used in the clinical development of a placental malaria vaccine.
    Pehrson C; Heno KK; Adams Y; Resende M; Mathiesen L; Soegaard M; de Jongh WA; Theander TG; Salanti A; Nielsen MA
    Vaccine; 2017 Jan; 35(4):610-618. PubMed ID: 28012775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites.
    Ampomah P; Stevenson L; Ofori MF; Barfod L; Hviid L
    Infect Immun; 2014 May; 82(5):1860-71. PubMed ID: 24566620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma and IL-10 mediate parasite-specific immune responses of cord blood cells induced by pregnancy-associated Plasmodium falciparum malaria.
    Brustoski K; Möller U; Kramer M; Petelski A; Brenner S; Palmer DR; Bongartz M; Kremsner PG; Luty AJ; Krzych U
    J Immunol; 2005 Feb; 174(3):1738-45. PubMed ID: 15661939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical and clinical development of the first placental malaria vaccine.
    Pehrson C; Salanti A; Theander TG; Nielsen MA
    Expert Rev Vaccines; 2017 Jun; 16(6):613-624. PubMed ID: 28434376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites.
    Ampomah P; Stevenson L; Ofori MF; Barfod L; Hviid L
    J Immunol; 2014 Jun; 192(11):5236-44. PubMed ID: 24760153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.
    Patel JC; Hathaway NJ; Parobek CM; Thwai KL; Madanitsa M; Khairallah C; Kalilani-Phiri L; Mwapasa V; Massougbodji A; Fievet N; Bailey JA; Ter Kuile FO; Deloron P; Engel SM; Taylor SM; Juliano JJ; Tuikue Ndam N; Meshnick SR
    Sci Rep; 2017 Aug; 7(1):7768. PubMed ID: 28801627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development.
    Hviid L
    Hum Vaccin; 2010 Jan; 6(1):84-9. PubMed ID: 19823032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women.
    Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing vaccines to prevent malaria in pregnant women.
    Tuikue-Ndam N; Deloron P
    Expert Opin Biol Ther; 2015; 15(8):1173-82. PubMed ID: 26051589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum.
    Diouf I; Fievet N; Doucouré S; Ngom M; Andrieu M; Mathieu JF; Gaye A; Thiaw OT; Deloron P
    J Reprod Immunol; 2007 Jun; 74(1-2):152-62. PubMed ID: 17194481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
    Pinto VV; Salanti A; Joergensen LM; Dahlbäck M; Resende M; Ditlev SB; Agger EM; Arnot DE; Theander TG; Nielsen MA
    Vaccine; 2012 Jan; 30(3):572-9. PubMed ID: 22122859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.